Possibilities of alternative pharmacological approaches to monotherapy for bacterial vaginosis in reproductive-aged patients

Lebedenko E.Yu., Gaida O.V., Mikhailenko Ya.V., Anufrieva V.G., Rymashevsky M.A., Sablina N. V., Bespalaya A. V.

1) Rostov State Medical University, Ministry of Health of the Russian Federation, Rostov-on-Don, Russia 2) Rostov Regional Clinical Hospital No. 2, Rostov-on-Don, Russia 3) Botkin Hospital, Moscow Healthcare Department, Moscow, Russia 4) Rostov Regional Perinatal Center, Rostov-on-Don, Russia
Objective: To present the authors’ own experience with monotherapy for bacterial vaginosis with vaginal gel (Vapigel) in reproductive-aged patients.
Materials and methods: The efficiency and compliance of monotherapy for bacterial vaginosis with intravaginal gel (Vapigel) were evaluated in 30patients on the basis of the time course of changes in clinical symptoms, vaginal fluid pH-metry, the quantitative characteristics of representatives of the vaginal microbiota, and treatment adherence.
Results: Vaginal gel (Vapigel) monotherapy for bacterial vaginosis eliminates subjective complaints and clinical symptoms of the disease in 29/30 (96.7%) patients, determines the detection rate for Lactobacillus spp. at a concentration of107 CFU/ml in 26/30(86.6%), and restores the physiological vaginal discharge pH level in 28/30 (93.3%). Adherence to the use of Vapigel was noted in 25/30 (83.3%) patients; no adverse events were observed in 30/30 (100.0%) patients.
Conclusion: Clinical efficacy, acceptability, absence of adverse events, and treatment refusals determine the advisability of using Vapigel as a monotherapy for bacterial vaginosis in reproductive-aged women as an important component in the implementation of measures to reduce the prescription of antimicrobial drugs in clinical practice.

Keywords

bacterial vaginosis
reproductive age
intravaginal gel
prebiotics
plant polysaccharides

References

  1. Глобальная стратегия ВОЗ по сдерживанию устойчивости к противоми- кробным препаратам [интернет]. Женева: ВОЗ; 2001. [WHO global strate-gy for containment of antimicrobial resistance. Geneva: WHO; 2001].
  2. Таточенко В.К. Резистентность к антибиотикам и как ее преодолеть. Комментарий к статье С.В. Ильиной «Нерациональное использова­ние антибиотиков в медицине: кризис антибиотикорезистентности, и что мы можем сделать». Педиатрическая фармакология. 2017; 14(6): 514-9. [Tatochenko V.K. Antibiotic resistance and how to overcome it. Commentary on the article by S.V. Ilyina «Irrational use of antibiotics in medicine: the crisis of antibiotic resistance, and what we can do». Pediatric Pharmacology. 2017; 14(6): 514-9 (in Russian)]. https://dx.doi.org/10.15690/v14i6.1835.
  3. ВОЗ. Глобальный план действий по борьбе с устойчивостью к противо- микробным препаратам [интернет]. Женева: ВОЗ; 2016. Доступно по: http://apps.who.int/iris/bitstre am/10665/254884/1/9789244509760-rus. pdf [WHO. Global Action Plan on Antimicrobial Resistance (in Russian)]. Available at: http://apps.who.int/iris/bitstre am/10665/254884/1/ 9789244509760-rus.pdf.
  4. European Centre for Disease Prevention and Control (ECDC). Last-line antibiotics are failing. 17 Nov 2016. Available at: https://ecdc. europa.eu/en/ news-events/last-line-antibiotics-are-failing.
  5. ВОЗ. Устойчивость к антибиотикам. Информационный бюллетень ВОЗ; 2017. [WHO. Antibiotic resistance. WHO newsletter. 2017. (in Russian)].
  6. Давыдов Д.С. Национальная стратегия Российской Федерации по преду­преждению распространения устойчивости патогенных микроорганизмов к антимикробным препаратам: трудности и перспективы сдерживания одной из глобальных биологических угроз XXI века. БИО препараты. Профилактика, диагностика, лечение. 2018; 18(1): 50-6. [Davydov D.S. The National Strategy of the Russian Federation for Preventing the Spread of Antimicrobial Resistance: Challenges and Prospects of Controlling One of the Global Biological Threats of the 21st Century. BIO preparations. Prevention, Diagnosis, Treatment. 2018; 18(1): 50-6. (in Russian)]. https://dx.doi.org/10.30895/2221-996X-2018-18-1-50-56.
  7. Намазова-Баранова Л.С., Баранов А.А. Антибиотикорезистентность в современном мире. Педиатрическая фармакология. 2017; 14(5): 341­54. https://dx.doi.org/10.15690/pf.v14i5.1782. [Namazova-Baranova L.S., Baranov A.A. Antibiotic resistance in the modern world. Pediatric Pharmacology. 2017; 14(5): 341-54 (in Russian)]. https://dx.doi.org/10.15690/pf.v14i5.1782.
  8. Ventola C.L. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015; 40(4): 277-83.
  9. Российское общество акушеров-гинекологов. Клинические рекоменда­ции по диагностике и лечению заболеваний, сопровождающихся пато­логическими выделениями из половых путей женщин. 2-е изд. М.: РОАГ; 2019. 56 c. [Russian Society of obstetricians-gynaecologists. Clinical guidelines for the diagnosis and treatment of diseases accompanied by pathological discharge from the genital tract of women. 2nd ed. M.: RSOG; 2019. 56 p. (in Russian)].
  10. Кузнецова И.В., Чилова Р.А. Бактериальный вагиноз и вульвовагинальный кандидоз. Акушерство и гинекология. 2018; 5: 143-9. [Kuznetsova I.V., Chilova R.A. Bacterial vaginosis and vulvovaginal candidiasis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; 5: 143-9 (in Russian)]. https://dx.doi.org/10.18565/aig.2018.5.143-149.
  11. Радзинский В.Е., Ордиянц И.М. Двухэтапная терапия вагинальных инфекций. М.: StatusPraesens; 2012. 16 с. [Radzinsky V.E., Ordiyants I.M. Two-step therapy for vaginal infections. : StatusPraesens; 2012. 16 p. (in Russian)].

Received 09.12.2021

Accepted 24.12.2021

About the Authors

Elizaveta Yu. Lebedenko, Doctor of Medicine, Head of the Department of Obstetrics and Gynecology No. 3, Rostov State Medical University, Ministry of Health of Russia, +7(863)252-24-65, Lebedenko08@mailru, 344022, Russia, Rostov-on-Don, per. Nahichevanskiy, 29.
Oksana V. Gaida, PhD (Med.), Associate Professor of the Department of Obstetrics and Gynecology, Rostov State Medical University,
Ministry of Health of Russia, gajdaoksana@mail.ru, https://orcid.org/0000-0002-6966-1793, 344022, Russia, Rostov-on-Don, per. Nahichevanskiy, 29.
Yana V. Mikhailenko, obstetrician-gynecologist of the Gynecological Department, Regional Hospital No. 2, Rostov-on-Don, +7(863)252-31-83, yanochka.podina@inboxru, 344023, Russia, Rostov-on-Don, 1st Cavalry Army str., 33.
Mikhail A. Rymashevskiy, assistant of the Department of Obstetrics and Gynecology, Rostov State Medical University, Ministry of Health of Russia, +7(863)285-32-13, mikhail.rymashevskiy@mail.ru, 344022, Russia, Rostov-on-Don, per. Nahichevanskiy, 29.
Vitaliya G. Anufrieva, obstetrician-gynecologist of the Gynecological Department, Rostov State Medical University, Ministry of Health of Russia, +7(863)234-38-66, vitaliya@list.ru, 344022, Russia, Rostov-on-Don, per. Nahichevanskiy, 29. Tel.:
Natalya V. Sablina, obstetrician-gynecologist, Gynecological Department, Botkin Hospital, Moscow Healthcare Department, +7(495)677-16-11, natalie_sablina@yahoo.de, https://orcid.org/0000-0002-8068-120Х, 125284, Russia, Moscow, 2nd Botkinsky pr-d, 5
Angelina V. Bespalaya, оbstetrician-gynecologist of the Maternity Department, State Perinatal Center of the Rostov Region, +7(863)235-50-18, angelina-koshka@yandex.ru, 344068, Russia, Rostov-on-Don, Bodraya str., 90.
Corresponding author: Elizaveta Yu. Lebedenko, Lebedenko08@mail.ru

Authors’ contributions: Lebedenko E.Yu. - research coordinator, development of the design of the investigation and its protocol, IRC, analysis of the findings, editing the text; Gaida O.V., Rymashevsky M.A. - collection and analysis of the findings, writing the text; Mikhailenko Ya.V., Anufrieva V.G., Sablina N.V., Bespalaya A.V. - collection and analysis of the findings.
Conflicts of interest: The authors declare that there are possible conflicts of interest.
Funding: The clinical trial has been conducted with the support of the Kinetik-Farm LLC, Russian Federation.
Patient Consent for Publication: All patients provided informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Lebedenko E.Yu., Gaida O.V., Mikhailenko Ya.V., Anufrieva V.G., Rymashevsky M.A., Sablina N. V., Bespalaya A. V. Possibilities of alternative pharmacological approaches to monotherapy for bacterial vaginosis in reproductive-aged patients. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2022; 1:129-134 (in Russian)
https://dx.doi.org/10.18565/aig.2022.1.129-134

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.